跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tracsiban - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tracsiban
Approved
STANDARD
Tracsiban
Hanlim Pharm. Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a148f8e6c618597e
Company
Hanlim Pharm. Co., Ltd.
Type
Standard
Approval Details
Approval Id
a148f8e6c618597e
Drug Approval Philippines Name
Tracsiban
Product Name
Tracsiban
Registration Number
DRP-14629
Brand Name
Tracsiban
Generic Name
Atosiban (as acetate)
Dosage Form
Solution for Injection (IM/IV/SC)
Dosage Strength
7.5 mg (equivalent to 7.953 mg Atosiban Acetate)/mL
Manufacturer
Hanlim Pharm. Co., Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Company Detail Path
/organization/hanlim-pharm-co-ltd
Issuance Date
11 September 2024
Expiry Date
11 September 2029
Pharmacologic Category
Other Gynecologicals
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a148f8e6c618597e
Type
Standard
Back to Philippines FDA Approvals